Accessibility Menu
Molecular Partners Ag logo

Molecular Partners Ag

(NASDAQ) MOLN

Current Price$4.10
Market Cap$147.42M
Since IPO (2021)-80%
5 Year-80%
1 Year+6%
1 Month-1%

Molecular Partners Ag Financials at a Glance

Market Cap

$147.42M

Revenue (TTM)

CHF 0.00

Net Income (TTM)

-CHF 64.16M

EPS (TTM)

-$1.93

P/E Ratio

-2.04

Dividend

$0.00

Beta (Volatility)

0.52 (Low)

Price

$4.10

Volume

16,472.58

Open

$4.10

Previous Close

$3.93

Daily Range

$4.10 - $4.14

52-Week Range

$3.41 - $5.36

Estimated Earnings Date

Aug 24, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Molecular Partners Ag

Industry

Biotechnology

Employees

149

CEO

Patrick Amstutz, PhD

Headquarters

Schlieren, 8952, CH

MOLN Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-66.19%

Return on Capital

-69.21%

Return on Assets

-66.25%

Earnings Yield

-49.02%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$147.42M

Shares Outstanding

37.51M

Volume

16.47K

Avg. Volume

5.51K

Financials (TTM)

Gross Profit

-CHF 1.81M

Operating Income

-CHF 61.52M

EBITDA

-CHF 61.93M

Operating Cash Flow

-CHF 53.80M

Capital Expenditure

-CHF 333.55K

Free Cash Flow

-CHF 54.13M

Cash & ST Invst.

CHF 78.53M

Total Debt

CHF 3.33M

Molecular Partners Ag Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

CHF 0.00

N/A

Gross Profit

-CHF 512.17K

+16.6%

Gross Margin

0.00%

N/A

Market Cap

$147.42M

N/A

Market Cap/Employee

$933.03K

N/A

Employees

158

N/A

Net Income

-CHF 13.14M

+29.5%

EBITDA

-CHF 12.64M

+27.1%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

CHF 78.53M

-40.0%

Total Debt

CHF 3.33M

+55.7%

Accounts Receivable

CHF 2.31M

-42.0%

Inventory

CHF 0.00

N/A

Long Term Debt

CHF 2.13M

+131.2%

Short Term Debt

CHF 1.21M

-1.0%

Return on Assets

-66.25%

N/A

Return on Invested Capital

-70.20%

N/A

Free Cash Flow

-CHF 14.47M

+17.5%

Operating Cash Flow

-CHF 14.47M

+15.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PEPGPepGen Inc.
$1.85+2.43%
CRBPCorbus Pharmaceuticals Holdings, Inc.
$9.35+3.09%
MISTMilestone Pharmaceuticals Inc.
$1.35+1.89%
CRDFCardiff Oncology, Inc.
$1.30+0.39%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$14.62+0.01%
CONLGraniteShares ETF Trust - GraniteShares 2x Long Coin Daily ETF
$5.54+0.10%
ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF
$12.76+0.05%
NOWLGraniteShares ETF Trust - GraniteShares 2x Long Now Daily ETF
$4.94+0.00%

Questions About MOLN

What is the current price of Molecular Partners Ag?

Molecular Partners Ag is trading at $4.11 per share.

What is the 52-week range for Molecular Partners Ag?

Over the past 52 weeks, Molecular Partners Ag has traded between $3.41 and $5.36.

How much debt does Molecular Partners Ag have?

As of the most recent reporting period, Molecular Partners Ag reported total debt of CHF 4.16M.

How much cash does Molecular Partners Ag have on hand?

Molecular Partners Ag reported CHF 98.03M in cash and cash equivalents in its most recent financial results.

What is Molecular Partners Ag’s dividend yield?

Molecular Partners Ag does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.